145 related articles for article (PubMed ID: 6379124)
1. Lymphokine-activated human blood monocytes destroy tumor cells but not normal cells under cocultivation conditions.
Fidler IJ; Kleinerman ES
J Clin Oncol; 1984 Aug; 2(8):937-43. PubMed ID: 6379124
[TBL] [Abstract][Full Text] [Related]
2. Activation of tumoricidal properties in human blood monocytes by liposomes containing lipophilic muramyl tripeptide.
Kleinerman ES; Erickson KL; Schroit AJ; Fogler WE; Fidler IJ
Cancer Res; 1983 May; 43(5):2010-4. PubMed ID: 6831430
[TBL] [Abstract][Full Text] [Related]
3. Tumoricidal activity of human monocytes activated in vitro by free and liposome-encapsulated human lymphokines.
Kleinerman ES; Schroit AJ; Fogler WE; Fidler IJ
J Clin Invest; 1983 Jul; 72(1):304-15. PubMed ID: 6348087
[TBL] [Abstract][Full Text] [Related]
4. Human monocyte-mediated cytotoxicity against herpes simplex virus-infected cells: activation of cytotoxic monocytes by free and liposome-encapsulated lymphokines.
Koff WC; Showalter SD; Chakrabarty MK; Hampar B; Ceccorulli LM; Kleinerman ES
J Leukoc Biol; 1985 Apr; 37(4):461-72. PubMed ID: 3882870
[TBL] [Abstract][Full Text] [Related]
5. Lysis of tumor cells by human blood monocytes by a mechanism independent of activation of the oxidative burst.
Kleinerman ES; Ceccorulli LM; Bonvini E; Zicht R; Gallin JI
Cancer Res; 1985 May; 45(5):2058-64. PubMed ID: 2985242
[TBL] [Abstract][Full Text] [Related]
6. Activation of tumoricidal properties in peripheral blood monocytes of patients with colorectal carcinoma.
Fidler IJ; Jessup JM; Fogler WE; Staerkel R; Mazumder A
Cancer Res; 1986 Feb; 46(2):994-8. PubMed ID: 3000591
[TBL] [Abstract][Full Text] [Related]
7. Activated human blood monocytes trigger the antitumor activity of blood polymorphonuclear cells.
Fidler IJ; Nii A; Tsao JY; Davis S; Kleinerman ES
Lymphokine Res; 1989; 8(4):427-37. PubMed ID: 2811474
[TBL] [Abstract][Full Text] [Related]
8. Ultrastructural studies of the interaction between liposome-activated human blood monocytes and allogeneic tumor cells in vitro.
Bucana CD; Hoyer LC; Schroit AJ; Kleinerman E; Fidler IJ
Am J Pathol; 1983 Jul; 112(1):101-11. PubMed ID: 6859224
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity to tumor cells of monocytes from normal individuals and cancer patients.
Gerrard TL; Terz JJ; Kaplan AM
Int J Cancer; 1980 Nov; 26(5):585-93. PubMed ID: 7239718
[TBL] [Abstract][Full Text] [Related]
10. Human lymphokine preparations which generate tumoricidal properties of human monocytes in vitro may be distinct from gamma interferon.
Kleinerman ES; Wiltrout RH; Zicht R; Fidler IJ
Cancer Immunol Immunother; 1985; 20(2):151-7. PubMed ID: 3930068
[TBL] [Abstract][Full Text] [Related]
11. Activation of monocyte-mediated tumoricidal activity in patients with acquired immunodeficiency syndrome.
Kleinerman ES; Ceccorulli LM; Zwelling LA; Twilley T; Herberman RB; Jacob J; Gelmann EP
J Clin Oncol; 1985 Jul; 3(7):1005-12. PubMed ID: 3926955
[TBL] [Abstract][Full Text] [Related]
12. Intracellular activation of human and rodent macrophages by human lymphokines encapsulated in liposomes.
Kleinerman ES; Fogler WE; Fidler IJ
J Leukoc Biol; 1985 May; 37(5):571-84. PubMed ID: 3920339
[TBL] [Abstract][Full Text] [Related]
13. Tumoricidal activity of macrophages isolated from human ascitic and solid ovarian carcinomas: augmentation by interferon, lymphokines and endotoxin.
Peri G; Polentarutti N; Sessa C; Mangioni C; Mantovani A
Int J Cancer; 1981 Aug; 28(2):143-52. PubMed ID: 6172388
[TBL] [Abstract][Full Text] [Related]
14. Potentiating effect of muramyl dipeptide and its lipophilic analog encapsulated in liposomes on tumor cell killing by human monocytes.
Sone S; Mutsuura S; Ogawara M; Tsubura E
J Immunol; 1984 Apr; 132(4):2105-10. PubMed ID: 6699409
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor and IL-1 associated with plasma membranes of activated human monocytes lyse monokine-sensitive but not monokine-resistant tumor cells whereas viable activated monocytes lyse both.
Ichinose Y; Bakouche O; Tsao JY; Fidler IJ
J Immunol; 1988 Jul; 141(2):512-8. PubMed ID: 3260254
[TBL] [Abstract][Full Text] [Related]
16. Macrophage antitumor activity in vitro. Comparative analysis of cytolytic, cytostatic, and cytotoxic activities of mouse macrophages and human monocytes.
Soldateschi D; Censini S; de Gori V; Antoni G; Tagliabue A; Boraschi D
Immunobiology; 1984 May; 166(3):251-62. PubMed ID: 6376332
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of the cytolytic activity of peripheral blood monocytes by lymphokines and interferon.
Fischer DG; Golightly MG; Koren HS
J Immunol; 1983 Mar; 130(3):1220-5. PubMed ID: 6401781
[TBL] [Abstract][Full Text] [Related]
18. Human monocyte-mediated cytotoxicity to K-562 cells: activation by lymphokines.
Hammerstrøm J
Scand J Immunol; 1979; 10(6):575-84. PubMed ID: 396667
[TBL] [Abstract][Full Text] [Related]
19. Human alveolar macrophage function: differences between smokers and nonsmokers.
Thomassen MJ; Barna BP; Wiedemann HP; Farmer M; Ahmad M
J Leukoc Biol; 1988 Nov; 44(5):313-8. PubMed ID: 2846725
[TBL] [Abstract][Full Text] [Related]
20. Human monocytes activated by immunomodulators in liposomes lyse herpesvirus-infected but not normal cells.
Koff WC; Fidler IJ; Showalter SD; Chakrabarty MK; Hampar B; Ceccorulli LM; Kleinerman ES
Science; 1984 Jun; 224(4652):1007-9. PubMed ID: 6426057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
